Multiple lines of evidence including ours from the present study reveal important contribution of G6PD/PPP dysfunction and consequent oxidative stress to PD pathogenesis and suggest that modulation of G6PD activity might be beneficial for PD treatment. The gene discussed is G6PD; the disease is Parkinson disease.